Dr. Iruela-Arispe on the Dr. Paul Janssen Award Symposium

Video

Dr. Luisa Iruela-Arispe from University of California, Los Angeles on the Dr. Paul Janssen Award Symposium

Luisa Iruela-Arispe, PhD, director, JCCC Cancer and Stem Cell Biology Program Area, professor and vice chair, Molecular, Cell, and Developmental Biology, University of California, Los Angeles (UCLA), discusses the highlights from the 2011 Dr. Paul Janssen Award Symposium, Wednesday, September 14, 2011, in New York City, NY.

The symposium highlighted the benefits of single agent bevacizumab (Avastin) and awarded the 2011 Dr. Paul Janssen Award for Biomedical Research to Napoleone Ferrara, MD, the discoverer of the vascular endothelial growth factor (VEGF) angiogenic-signaling molecule.

Angiogenesis breakthroughs and therapeutic applications were the focus of the one-day symposium; it focused specifically on bevacizumab and its impact on multiple individual lives. The need to work across multiple disciplines to enhance the drugs efficacy and possible combinations with other targeted therapeutics was the main topic of discussion.

Related Videos
Emmanuel Antonarakis, MD, associate director, Translational Research, Masonic Cancer Center, University of Minnesota, Clark Endowed Professor of Medicine, University of Minnesota Medical School
Gautam Jha, MD, medical director, M Health Fairview Masonic Cancer Clinic and the Advanced Treatment Center at the M Health Fairview Clinics and Surgery Center—Minneapolis, chair, cancer committee, M Health Fairview Ridges Hospital
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute